180 related articles for article (PubMed ID: 15138764)
1. Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain.
Ortega-Alvaro A; Acebes I; Saracíbar G; Echevarría E; Casis L; Micó JA
Psychopharmacology (Berl); 2004 Nov; 176(3-4):305-11. PubMed ID: 15138764
[TBL] [Abstract][Full Text] [Related]
2. Tolerance induced by non-opioid analgesic microinjections into rat's periaqueductal gray and nucleus raphe.
Tsiklauri N; Nozadze I; Gurtskaia G; Berishvili V; Abzianidze E; Tsagareli M
Georgian Med News; 2010 Mar; (180):47-55. PubMed ID: 20413817
[TBL] [Abstract][Full Text] [Related]
3. Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia.
Maione S; Starowicz K; Cristino L; Guida F; Palazzo E; Luongo L; Rossi F; Marabese I; de Novellis V; Di Marzo V
J Neurophysiol; 2009 May; 101(5):2411-22. PubMed ID: 19297510
[TBL] [Abstract][Full Text] [Related]
4. Lithium alters mu-opioid receptor expression in the rat brain.
de Gandarias JM; Acebes I; Echevarría E; Vegas L; Abecia LC; Casis L
Neurosci Lett; 2000 Jan; 279(1):9-12. PubMed ID: 10670775
[TBL] [Abstract][Full Text] [Related]
5. Interactions between social stress and morphine in the periaqueductal gray: effects on affective vocal and reflexive pain responses in rats.
Vivian JA; Miczek KA
Psychopharmacology (Berl); 1999 Sep; 146(2):153-61. PubMed ID: 10525750
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antinociceptive actions and tolerance development produced by morphine-fentanyl coadministration: correlation with μ-opioid receptor internalization.
Silva-Moreno A; Gonzalez-Espinosa C; León-Olea M; Cruz SL
Eur J Pharmacol; 2012 Jan; 674(2-3):239-47. PubMed ID: 22079772
[TBL] [Abstract][Full Text] [Related]
7. ORL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing.
Monteillet-Agius G; Fein J; Anton B; Evans CJ
J Comp Neurol; 1998 Sep; 399(3):373-83. PubMed ID: 9733084
[TBL] [Abstract][Full Text] [Related]
8. Placebo effects on human mu-opioid activity during pain.
Wager TD; Scott DJ; Zubieta JK
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic neural circuits between dorsal midbrain neurons that control fear-induced responses and seizure activity and nuclei of the pain inhibitory system elaborating postictal antinociceptive processes: a functional neuroanatomical and neuropharmacological study.
Freitas RL; Ferreira CM; Ribeiro SJ; Carvalho AD; Elias-Filho DH; Garcia-Cairasco N; Coimbra NC
Exp Neurol; 2005 Feb; 191(2):225-42. PubMed ID: 15649478
[TBL] [Abstract][Full Text] [Related]
10. Agomelatine potentiates anti-nociceptive effects of morphine in a mice model for diabetic neuropathy: involvement of NMDA receptor subtype NR1 within the raphe nucleus and periaqueductal grey.
Ozcan S; Bulmus O; Ulker N; Canpolat S; Etem EO; Oruc S; Yardimci A; Bulmus FG; Ayar A; Kelestimur H; Ozcan M
Neurol Res; 2020 Jul; 42(7):554-563. PubMed ID: 32336224
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective opioid receptor antagonists on alcohol-induced and nicotine-induced antinociception.
Campbell VC; Taylor RE; Tizabi Y
Alcohol Clin Exp Res; 2007 Aug; 31(8):1435-40. PubMed ID: 17550364
[TBL] [Abstract][Full Text] [Related]
12. Chronic paroxetine increases [3H]nociceptin binding in rat dorsal raphe nucleus.
Vilpoux C; Naudon L; Costentin J; Leroux-Nicollet I
Neuroreport; 2002 Jan; 13(1):111-4. PubMed ID: 11924870
[TBL] [Abstract][Full Text] [Related]
13. Nefazodone alters NPY immunostaining in rat arcuate-paraventricular projection without changes in food intake and body weight.
Saracíbar G; Casado A; Rodríguez VM; Portillo MP; Macarulla MT; Abecia LC; Echevarría E; Casis L
Nutr Neurosci; 2002 Oct; 5(5):353-8. PubMed ID: 12385598
[TBL] [Abstract][Full Text] [Related]
14. Differential opioid action on sensory and affective cerebral pain processing.
Oertel BG; Preibisch C; Wallenhorst T; Hummel T; Geisslinger G; Lanfermann H; Lötsch J
Clin Pharmacol Ther; 2008 Apr; 83(4):577-88. PubMed ID: 18030306
[TBL] [Abstract][Full Text] [Related]
15. Effects of imipramine administration on mu-opioid receptor immunostaining in the rat forebrain.
de Gandarias JM; Echevarria E; Acebes I; Silio M; Casis L
Arzneimittelforschung; 1998 Jul; 48(7):717-9. PubMed ID: 9706370
[TBL] [Abstract][Full Text] [Related]
16. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala.
Finnegan TF; Chen SR; Pan HL
J Pharmacol Exp Ther; 2005 Feb; 312(2):441-8. PubMed ID: 15388784
[TBL] [Abstract][Full Text] [Related]
17. Effects of nefazodone on the development of experimentally induced tumors in stressed rodents.
Freire-Garabal M; Rey-Méndez M; García-Vallejo LA; Balboa J; Suárez JM; Rodrigo E; Brenlla J; Núñez MJ
Psychopharmacology (Berl); 2004 Nov; 176(3-4):233-8. PubMed ID: 15164159
[TBL] [Abstract][Full Text] [Related]
18. Opioid sensitivity of nucleus raphe magnus ater analgesia by nonsteroidal anti-inflammatory drugs.
Nozadze I; Tsiklauri N; Gurtskaia G; Abzianidze E; Tsagareli MG
Georgian Med News; 2011 Jan; (190):50-5. PubMed ID: 21346268
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic desipramine treatment on alpha2-adrenoceptors and mu-opioid receptors in the guinea pig cortex and hippocampus.
Giaroni C; Canciani L; Zanetti E; Giuliani D; Pisani R; Oldrini R; Moro E; Trinchera M; Crema F; Lecchini S; Frigo G
Eur J Pharmacol; 2008 Jan; 579(1-3):116-25. PubMed ID: 18028907
[TBL] [Abstract][Full Text] [Related]
20. The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.
Dremencov E; Gispan-Herman I; Rosenstein M; Mendelman A; Overstreet DH; Zohar J; Yadid G
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):141-7. PubMed ID: 14687868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
